PAPADOPOULOS STELIOS 4
4 · EXELIXIS, INC. · Filed May 16, 2025
Insider Transaction Report
Form 4
EXELIXIS, INC.EXEL
PAPADOPOULOS STELIOS
Director
Transactions
- Exercise/Conversion
Common Stock
2025-05-15$19.77/sh+20,634$407,934→ 1,300,050 total - Sale
Common Stock
2025-05-15$44.35/sh−20,634$915,118→ 1,279,416 total - Exercise/Conversion
Common Stock
2025-05-15$20.50/sh+15,874$325,417→ 1,295,290 total - Sale
Common Stock
2025-05-15$44.35/sh−15,874$704,012→ 1,279,416 total - Exercise/Conversion
Option (right to buy)
2025-05-15−20,634→ 0 totalExercise: $19.77From: 2019-05-23Exp: 2026-05-22→ Common Stock (20,634 underlying) - Exercise/Conversion
Option (right to buy)
2025-05-15−15,874→ 0 totalExercise: $20.50From: 2018-05-24Exp: 2025-05-23→ Common Stock (15,874 underlying)
Footnotes (3)
- [F1]Includes 18,838 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
- [F2]The option, representing the right to purchase a total of 20,634 shares of Common Stock, became fully exercisable on May 23, 2019.
- [F3]The option, representing the right to purchase a total of 15,874 shares of Common Stock, became fully exercisable on May 24, 2018.